4.9 • 876 Ratings
🗓️ 14 March 2025
⏱️ 28 minutes
🧾️ Download transcript
Listener feedback, resistant hypertension, K-binders for MRA use in heart failure, nutritional epidemiology, and a positive study for vitamin D are the topics John Mandrola, MD, discusses in this week's podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I Listener Feedback
II Resistant HTN
https://www.medscape.com/viewarticle/positive-topline-results-lorundrostat-hypertension-2025a100062e
III K-Binding
IV Butter vs Plant-based Oils and Mortality
V Vitamin D
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact [email protected]
Click on a timestamp to play from that location
0:00.0 | You're listening to This Week in Cardiology from the heart.org, Medscape Cardiology. |
0:05.7 | This podcast is intended for health care professionals only. |
0:08.8 | Any views expressed are the presenters own and do not necessarily reflect the views of WebMD or Medscape. |
0:15.0 | Hi, everyone. |
0:16.3 | This is John Mandrola from the Heart.org Medscape Cardiology, and this is this week in |
0:21.9 | cardiology for March 14th, 2025. This week I'll do some listener feedback, resistant hypertension, |
0:30.6 | potassium binders for MRI use and heart failure, nutritional epidemiology, and a positive study for vitamin D. |
0:40.7 | First up, some listener feedback. Last week, I strongly criticized a CAD trial, mostly on |
0:48.8 | methodologic grounds. The trial tested the use of CAC scoring, coronary calcium scoring, to reduce plaque volume in intermediate |
0:57.9 | risk patients with a family history of coronary disease. The trial was positive, but its trial |
1:04.0 | procedures precluded making any reliable clinical judgments. At least that was my argument. |
1:13.7 | This week, a Medscape journalist is working on a newspiece for the CAD trial, and he reached out to me for comment regarding a comments |
1:19.8 | the senior author made about my appraisal last week. Quote, I'm fascinated by the internet phenomenon |
1:27.1 | of opinion propagation. |
1:29.4 | There's no need to propose a solution to a problem just to denigrate any approaches other |
1:34.2 | than the status quo. |
1:36.1 | Nothing will ever change his mind because an outcomes trial with the required 20-year time |
1:41.0 | horizon will never be done. |
1:43.7 | Now, I'm not sure that this comment from the |
1:46.3 | senior author about my comments will make it into the news article, but I include it because it is a |
1:52.2 | comment I have heard from academic researchers before. In fact, the former FDA director, Dr. Robert |
1:58.8 | Caliph, once demeaned non-academic opinion writers on an internet |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Medscape Podcasts, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Medscape Podcasts and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.